Clariant is launching high-performing pharmaceutical ingredients to support the evolution of safe and effective medicines
This approval reflects company’s unwavering commitment that the quality assurance
New indication supported by the MANDARA trial which showed nearly 60% of patients achieved remission and 41% of patients fully stopped taking oral corticosteroids
The new facility further improves the operational efficiency and readies the site for the completion of the new large-scale production plant
The partnership will provide health plans with an out-of-the-box compliance solution for CMS-9115 and CMS-0057 rules
MoCRA mandates that all facilities involved in the manufacturing and processing of cosmetic products for sale in the United States
Stringent regulatory environments can make OEMs reluctant to change processes and materials for approved medical devices
Sigachi's entry into the coatings market is strategically timed to capitalize on the industry's growth potential
This is in partnership with Mepro Pharmaceuticals which have successfully developed and commercialised the Albendazole Chewable formulation
To co-develop and co-commercialize MK-6070, an investigational delta-like ligand 3 (DLL3) targeting T-cell engager, worldwide except for Japan where Merck retains exclusive rights
Subscribe To Our Newsletter & Stay Updated
